Navigation Links
NIH study describes new method for tracking T cells in HIV patients
Date:2/3/2014

WHAT:

A team of researchers has reported a novel method for tracking CD4+ T cells in people infected with HIV. CD4+ T cells are critical for immune defense against an array of pathogens and are a primary target of HIV. In the study, researchers used a unique, replication-incompetent (defective) form of HIV identified in a patient in the early 1990s. The defective virus had integrated into the genome of a single CD4+ T cell. Like a barcode, this "provirus" marked the originally infected CD4+ T cell and its progeny, enabling researchers to track its lineage for 17 years. This new method allows scientists to distinguish dividing cells from dying ones, something that has not been possible with existing labeling techniques, but is essential for studying how immune cells survive HIV infection.

The study, published in the online issue of AIDS, was conducted by Hiromi Imamichi, Ph.D., H. Clifford Lane, M.D., and others in the Laboratory of Immunoregulation at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The cell lineage is part of a subset of CD4+ T cells called "effector memory" (TEM) cells. This distinction is significant because it is currently believed that TEM cells last for only days or weeks. The NIAID investigators demonstrated that this subpopulation of T cells can persist for at least 17 years.

The researchers also observed in the blood cells of patients a higher frequency of defective HIV proviruses than what has been reported in previous work. Although these defective variants cannot produce an infectious virus, many retain the ability to generate small pieces of HIV, leading the researchers to speculate that these "foreign materials" within CD4+ T cells may play a key role in the ongoing immune activation that is characteristic of HIV infection, including in patients with "undetectable" virus in their blood.


'/>"/>

Contact: Linda Huynh
linda.huynh@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
Source:Eurekalert

Page: 1

Related medicine news :

1. NIH study offers insight into why cancer incidence increases with age
2. Tighter economic regulation needed to reverse obesity epidemic -- study
3. Kessler Foundation MS researchers study predictors of employment status
4. U of Maryland study: Partnership may help address cancer, health disparities
5. Study uncovers molecular keys to invasive bladder cancer
6. Study finds mammography beneficial for younger women
7. Infection control practices not adequately implemented at many hospital ICUs: study
8. Study: Oropharyngeal cancer on the rise in young adults
9. Autism Speaks study finds advances towards universal early screening
10. Future directions for landmark diabetes study in journal Diabetes Care
11. Study examines repeat colonoscopy in patients with polyps referred for surgery without biopsy-proven cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... (PRWEB) May 22, 2015 Bryce Henson, ... Anaheim Fit Body Boot Camp, recently accepted his program’s ... quickly after the launch of his location evidences the ... Anaheim community. , Fit Body Boot Camp is the ... camp franchise with hundreds of locations across North America, ...
(Date:5/22/2015)... 2015 Yisrayl Hawkins, Pastor and Overseer at ... new letter calling on religious leaders to make changes in ... published on his blog, discusses the history of war, how ... stop it. Yisrayl says mankind was created to lead peaceful, ... today’s society. , “Yahweh created mankind, according to His ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 India Network ... and developmental projects in rural India. India Network Visitor ... community projects that continues to help hundreds and thousands ... to sponsor a music concert by famous playback singer ... the Hindu Society of Central Florida activities. ...
(Date:5/21/2015)... WellCare Health Plans, Inc. (NYSE: WCG) announced today that its ... Kids Corporation (FHKC) to continue to provide managed care services ... Florida Healthy Kids (FHK) program. Pending execution, the two-year contract ... for two additional years at FHKC’s discretion. , Staywell will ... who live in Regions 1, 2, 3, 4, 5, 8, ...
(Date:5/21/2015)... 2015 Ticket Down is a reliable source for ... vs. Guatemala on Friday, July 3rd at LP Field in ... a fan of international soccer. The number of chances to watch ... soil is growing at a large clip. Over the past several ... the USA to play in front of the American people. The ...
Breaking Medicine News(10 mins):Health News:Healthy Living Brought to Anaheim— New Fitness Boot Camp Acquires 100 Clients 2Health News:Yisrayl Hawkins Calls on All Religions to Wake Up and Make Drastic Changes to End Suffering in New Letter 2Health News:India Network Visitor Health Insurance Announces Corporate Sponsorship of Anuradha Paudwal Musical in Orlando to Help Fundraise for Hindu Society of Central Florida. 2Health News:WellCare Selected to Continue Participating in the Florida Healthy Kids Program, Will Serve Nine Florida Regions Under the New Contract 2Health News:USA vs. Guatemala Tickets: Ticket Down Slashes United States Men's Soccer Team (USMNT) vs. Guatemala Tickets at LP Field in Nashville on 7/3/15 2
... much more than// allergens from dust mites or pets. ... Health Sciences, US, said that incidence of allergens from ... areas of the cities. ,The researchers had ... found out that there seems to be a significant ...
... People who have been suffering from chronic lower back pain ... surgical spine fusion. This is done when no other treatment ... recent study in the British Medical Journal reveled that in ... procedure for people who do not have enough finance to ...
... have reportd that exposure to pesticides may raise the ... is exposed to the pesticides the highre are his ... about 3000 people in Europan countries who either have ... and exposed to risk factors like pesticides. Researchers say ...
... College of Medicine brought to light that injecting ceramide// into ... breast cancer cells. ,Ceramide is a natural substance ... used to get better results out of breast cancer treatments. ... ,However injecting ceramide in the usual way into ...
... said in a new study that there’s adequate proof that ... of the elderly frequenting the bathroom more. ,Researchers had ... voiding flow rate and detrusor contraction strength from 95 females ... happens is that functionality of the bladder and the urethra ...
... found out that sex differences in sleep patterns do exist, ... had carried out a national survey of 39,588 people of ... city of Taiwan. The researchers considered several factors other than ... ,The results of the study had shown that there ...
Cached Medicine News:
(Date:5/22/2015)... , May 22, 2015 Today, ... central nervous system stimulant indicated for the treatment ... patients beginning Summer 2015. The ... received approval from the U.S. Food and Drug ... an extended-release formulation of methylphenidate capsule with an ...
(Date:5/22/2015)... May 22, 2015 AcelRx Pharmaceuticals, Inc. (Nasdaq: ... the development and commercialization of innovative therapies for the ... interim chief executive officer Howie Rosen will ... financial officer Tim Morris will be presenting ... two presentations are as follows: Jefferies 2015 ...
(Date:5/21/2015)... , May 21, 2015  When Ryan ... the side of his neck, he figured ... a couple weeks off from weight lifting. ... away.                               A series ... was referred to Michel Kliot, MD ...
Breaking Medicine Technology:Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 2Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 3Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 4Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 5Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 6AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences In June 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 4
... Company, Limited (hereafter, Daiichi Sankyo), announced today that the ... (JAN: Edoxaban Tosilate Hydrate, INN:edoxaban) 15 mg and 30 ... Welfare in Japan. Edoxaban, which is being ... anticoagulant that specifically, reversibly and directly inhibits the enzyme, ...
... Ontario, April 21, 2011 Valeant Pharmaceuticals International, Inc. ... the following statement to shareholders of Cephalon, Inc. (NASDAQ: ... today, the Cephalon Board of Directors stated that it ... Company,s alternatives and options – and is focused on ...
Cached Medicine Technology:Daiichi Sankyo Receives First Market Approval in Japan for LIXIANA® (edoxaban), a Direct Oral Factor Xa Inhibitor, for the Prevention of Venous Thromboembolism after Major Orthopedic Surgery 2Daiichi Sankyo Receives First Market Approval in Japan for LIXIANA® (edoxaban), a Direct Oral Factor Xa Inhibitor, for the Prevention of Venous Thromboembolism after Major Orthopedic Surgery 3Daiichi Sankyo Receives First Market Approval in Japan for LIXIANA® (edoxaban), a Direct Oral Factor Xa Inhibitor, for the Prevention of Venous Thromboembolism after Major Orthopedic Surgery 4Valeant Pharmaceuticals Responds to Cephalon Board's Letter 2Valeant Pharmaceuticals Responds to Cephalon Board's Letter 3Valeant Pharmaceuticals Responds to Cephalon Board's Letter 4
An enzyme linked immunoassay (ELISA) for the detection and semiquantitationof IgG and IgM antibodies to 2-GP1, as an aid in assessingthe risk of thrombosis in patients with Systemic Lupus Erythematos...
An enzyme linked immunoassay (ELISA) for the detection and semiquantitation of IgG, IgA or IgM anticardiolipin antibodies, as an aid in assessing the risk of thrombosis in individuals with Systemic L...
The ImagingPlanet 70 mm surgical microscope video adapter: superior optical quality and precise engineering make this 70 mm focal length adapter an excellent decision for use with your Zeiss surgical...
The ImagingPlanet 55 mm surgical microscope video adapter: superior optical quality and precise engineering make this 55mm focal length adapter an excellent decision for use with your Leica surgical ...
Medicine Products: